Rescue of tau-induced synaptic transmission pathology by paclitaxel

Frontiers in Cellular Neuroscience

Volumn 8, Issue FEB, 2014, Pages

  Erez, Hadas ^a   Shemesh, Or A ^a   Spira, Micha E ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Aplysia; Homosynaptic depression; Mutant human tau; Paclitaxel; Tauopathy; Vesicle stores

Indexed keywords

EID: 84893647317     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00034     Document Type: Article

References (94)

1. Alldred, M. J., Duff, K. E., and Ginsberg, S. D. (2012). Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol. Dis. 45, 751-762. doi: 10.1016/j.nbd.2011.10.022
2. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639. doi: 10.1212/wnl.42.3.631
3. Baas, P. W., and Qiang, L. (2005). Neuronal microtubules: when the MAP is the roadblock. Trends Cell Biol. 15, 183-187. doi: 10.1016/j.tcb.2005.02.001
4. Bailey, C. H., and Chen, M. (1988). Long-term memory in Aplysia modulates the total number of varicosities of single identified sensory neurons. Proc. Natl. Acad. Sci. U S A 85, 2373-2377. doi: 10.1073/pnas.85.7.2373
5. Bailey, C. H., and Kandel, E. R. (2008). Synaptic remodeling, synaptic growth and the storage of long-term memory in Aplysia. Prog. Brain Res. 169, 179-198. doi: 10.1016/s0079-6123(07)00010-6
6. Ballatore, C., Brunden, K. R., Huryn, D. M., Trojanowski, J. Q., Lee, V. M., and Smith, A. B. 3rd, et al. (2012). Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies. J. Med. Chem. 55, 8979-8996. doi: 10.1021/jm301079z
7. Ballatore, C., Lee, V. M., and Trojanowski, J. Q. (2007). Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672. doi: 10.1038/nrn2194
8. Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., et al. (2010). Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS One 5:e15477. doi: 10.1371/journal.pone.0015477
9. Braha, O., Dale, N., Hochner, B., Klein, M., Abrams, T. W., and Kandel, E. R. (1990). Second messengers involved in the two processes of presynaptic facilitation that contribute to sensitization and dishabituation in Aplysia sensory neurons. Proc. Natl. Acad. Sci. U S A 87, 2040-2044. doi: 10.1073/pnas.87.5.2040
10. Brandt, R., Leger, J., and Lee, G. (1995). Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340. doi: 10.1083/jcb.131.5.1327
11. Brunden, K. R., Ballatore, C., Crowe, A., Smith, A. B. 3rd, Lee, V. M., and Trojanowski, J. Q. (2010a). Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp. Neurol. 223, 304-310. doi: 10.1016/j.expneurol.2009.08.031
12. Brunden, K. R., Ballatore, C., Lee, V. M., Smith, A. B. 3rd, and Trojanowski, J. Q. (2012). Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. Biochem. Soc. Trans. 40, 661-666. doi: 10.1042/bst20120010
13. Brunden, K. R., Trojanowski, J. Q., and Lee, V. M. (2009). Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 8, 783-793. doi: 10.1038/nrd2959
14. Brunden, K. R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J. S., Hogan, A. M., et al. (2010b). Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30, 13861-13866. doi: 10.1523/jneurosci.3059-10.2010
15. Bykhovskaia, M. (2011). Synapsin regulation of vesicle organization and functional pools. Semin. Cell Dev. Biol. 22, 387-392. doi: 10.1016/j.semcdb.2011.07.003
16. Chakroborty, S., Kim, J., Schneider, C., Jacobson, C., Molgo, J., and Stutzmann, G. E. (2012). Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J. Neurosci. 32, 8341-8353. doi: 10.1523/jneurosci.0936-12.2012
17. Chee, F., Mudher, A., Newman, T. A., Cuttle, M., Lovestone, S., and Shepherd, D. (2006). Overexpression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Biochem. Soc. Trans. 34, 88-90. doi: 10.1042/bst0340088
18. Chee, F. C., Mudher, A., Cuttle, M. F., Newman, T. A., Mackay, D., Lovestone, S., et al. (2005). Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol. Dis. 20, 918-928. doi: 10.1016/j.nbd.2005.05.029
19. Coleman, P. D., and Yao, P. J. (2003). Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 24, 1023-1027. doi: 10.1016/j.neurobiolaging.2003.09.001
20. Crimins, J. L., Rocher, A. B., and Luebke, J. I. (2012). Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol. 124, 777-795. doi: 10.1007/s00401-012-1038-9
21. Crimins, J. L., Rocher, A. B., Peters, A., Shultz, P., Lewis, J., and Luebke, J. I. (2011). Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy. Acta Neuropathol. 122, 551-564. doi: 10.1007/s00401-011-0877-0
22. Cuchillo-Ibanez, I., Seereeram, A., Byers, H. L., Leung, K. Y., Ward, M. A., Anderton, B. H., et al. (2008). Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J. 22, 3186-3195. doi: 10.1096/fj.08-109181
23. Dale, N., and Kandel, E. R. (1990). Facilitatory and inhibitory transmitters modulate spontaneous transmitter release at cultured Aplysia sensorimotor synapses. J. Physiol. 421, 203-222.
24. Dixit, R., Ross, J. L., Goldman, Y. E., and Holzbaur, E. L. (2008). Differential regulation of dynein and kinesin motor proteins by tau. Science 319, 1086-1089. doi: 10.1126/science.1152993
25. Eckermann, K., Mocanu, M. M., Khlistunova, I., Biernat, J., Nissen, A., Hofmann, A., et al. (2007). The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem. 282, 31755-31765. doi: 10.1074/jbc.m705282200
26. Fioravante, D., Liu, R. Y., Netek, A. K., Cleary, L. J., and Byrne, J. H. (2007). Synapsin regulates Basal synaptic strength, synaptic depression, and serotonin-induced facilitation of sensorimotor synapses in Aplysia. J. Neurophysiol. 98, 3568-3580. doi: 10.1152/jn.00604.2007
27. Frost, B., and Diamond, M. I. (2010). Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159. doi: 10.1038/nrn2786
28. Ghirardi, M., Braha, O., Hochner, B., Montarolo, P. G., Kandel, E. R., and Dale, N. (1992). Roles of PKA and PKC in facilitation of evoked and spontaneous transmitter release at depressed and nondepressed synapses in Aplysia sensory neurons. Neuron 9, 479-489. doi: 10.1016/0896-6273(92)90185-g
29. Giannakopoulos, P., Herrmann, F. R., Bussiere, T., Bouras, C., Kovari, E., Perl, D. P., et al. (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60, 1495-1500. doi: 10.1212/01.wnl.0000063311.58879.01
30. Gingrich, K. J., and Byrne, J. H. (1985). Simulation of synaptic depression, posttetanic potentiation, and presynaptic facilitation of synaptic potentials from sensory neurons mediating gill-withdrawal reflex in Aplysia. J. Neurophysiol. 53, 652-669.
31. Glanzman, D. L. (2009). Habituation in Aplysia: the Cheshire cat of neurobiology. Neurobiol. Learn. Mem. 92, 147-154. doi: 10.1016/j.nlm.2009.03.005
32. Goedert, M., and Jakes, R. (2005). Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 1739, 240-250. doi: 10.1016/j.bbadis.2004.08.007
33. Hall, G. F., Lee, V. M., Lee, G., and Yao, J. (2001). Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am. J. Pathol. 158, 235-246. doi: 10.1016/s0002-9440(10)63962-4
34. Hochgrafe, K., Sydow, A., and Mandelkow, E. M. (2013). Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology. FEBS J. 280, 4371-4381. doi: 10.1111/febs.12250
35. Hochner, B., Klein, M., Schacher, S., and Kandel, E. R. (1986). Additional component in the cellular mechanism of presynaptic facilitation contributes to behavioral dishabituation in Aplysia. Proc. Natl. Acad. Sci. U S A 83, 8794-8798. doi: 10.1073/pnas.83.22.8794
36. Hollenbeck, P. J., and Saxton, W. M. (2005). The axonal transport of mitochondria. J. Cell Sci. 118, 5411-5419. doi: 10.1242/jcs.02745
37. Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., et al. (2010). Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081. doi: 10.1016/j.neuron.2010.11.030
38. Ittner, L. M., and Gotz, J. (2011). Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72. doi: 10.1038/nrn2967
39. Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., Van Eersel, J., et al. (2010). Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397. doi: 10.1016/j.cell.2010.06.036
40. Jin, I., Kandel, E. R., and Hawkins, R. D. (2011). Whereas short-term facilitation is presynaptic, intermediate-term facilitation involves both presynaptic and postsynaptic protein kinases and protein synthesis. Learn. Mem. 18, 96-102. doi: 10.1101/lm.1949711
41. Jordan, M. A., and Kamath, K. (2007). How do microtubule-targeted drugs work? An overview. Curr. Cancer Drug Targets 7, 730-742. doi: 10.2174/156800907783220417
42. Kandel, E. R. (2001). The molecular biology of memory storage: a dialog between genes and synapses. Biosci. Rep. 21, 565-611. doi: 10.1023/A:1014775008533
43. Khoutorsky, A., and Spira, M. E. (2005). Calcium-activated proteases are critical for refilling depleted vesicle stores in cultured sensory-motor synapses of Aplysia. Learn. Mem. 12, 414-422. doi: 10.1101/lm.92105
44. Kopeikina, K. J., Polydoro, M., Tai, H. C., Yaeger, E., Carlson, G. A., Pitstick, R., et al. (2013). Synaptic alterations in the rTg4510 mouse model of tauopathy. J. Comp. Neurol. 521, 1334-1353. doi: 10.1002/cne.23234
45. Kraemer, B. C., Zhang, B., Leverenz, J. B., Thomas, J. H., Trojanowski, J. Q., and Schellenberg, G. D. (2003). Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. U S A 100, 9980-9985. doi: 10.1073/pnas.1533448100
46. Kremer, A., Maurin, H., Demedts, D., Devijver, H., Borghgraef, P., and Van Leuven, F. (2011). Early improved and late defective cognition is reflected by dendritic spines in Tau. P301L mice. J. Neurosci. 31, 18036-18047. doi: 10.1523/jneurosci.4859-11.2011
47. Lee, V. M., Daughenbaugh, R., and Trojanowski, J. Q. (1994). Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol. Aging 15(Suppl. 2), S87-S89. doi: 10.1016/0197-4580(94)90179-1
48. Llinas, R., Mcguinness, T. L., Leonard, C. S., Sugimori, M., and Greengard, P. (1985). Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. Proc. Natl. Acad. Sci. U S A 82, 3035-3039. doi: 10.1073/pnas.82.9.3035
49. Mandelkow, E. M., Stamer, K., Vogel, R., Thies, E., and Mandelkow, E. (2003). Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 24, 1079-1085. doi: 10.1016/j.neurobiolaging.2003.04.007
50. Manseau, F., Fan, X., Hueftlein, T., Sossin, W., and Castellucci, V. F. (2001). Ca2+-independent protein kinase C Apl II mediates the serotonin-induced facilitation at depressed aplysia sensorimotor synapses. J. Neurosci. 21, 1247-1256.
51. Mayford, M., Siegelbaum, S. A., and Kandel, E. R. (2012). Synapses and memory storage. Cold Spring Harb. Perspect. Biol. 4:a005751. doi: 10.1101/cshperspect.a005751
52. Michaelis, M. L., Ansar, S., Chen, Y., Reiff, E. R., Seyb, K. I., Himes, R. H., et al. (2005). β-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J. Pharmacol. Exp. Ther. 312, 659-668. doi: 10.1124/jpet.104.074450
53. Michaelis, M. L., Dobrowsky, R. T., and Li, G. (2002). Tau neurofibrillary pathology and microtubule stability. J. Mol. Neurosci. 19, 289-293. doi: 10.1385/jmn:19:3:289
54. Michaelis, M. L., Ranciat, N., Chen, Y., Bechtel, M., Ragan, R., Hepperle, M., et al. (1998). Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J. Neurochem. 70, 1623-1627. doi: 10.1046/j.1471-4159.1998.70041623.x
55. Mocanu, M. M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., et al. (2008). The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748. doi: 10.1523/jneurosci.2824-07.2008
56. Moreno, H., Choi, S., Yu, E., Brusco, J., Avila, J., Moreira, J. E., et al. (2011). Blocking effects of human tau on squid giant synapse transmission and its prevention by T-817 MA. Front. Synaptic Neurosci. 3:3. doi: 10.3389/fnsyn.2011.00003
57. Morfini, G. A., Burns, M., Binder, L. I., Kanaan, N. M., Lapointe, N., Bosco, D. A., et al. (2009). Axonal transport defects in neurodegenerative diseases. J. Neurosci. 29, 12776-12786. doi: 10.1523/JNEUROSCI.3463-09.2009
58. Nixon, R. A., Yang, D. S., and Lee, J. H. (2008). Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4, 590-599.
59. Peris, L., Wagenbach, M., Lafanechere, L., Brocard, J., Moore, A. T., Kozielski, F., et al. (2009). Motor-dependent microtubule disassembly driven by tubulin tyrosination. J. Cell Biol. 185, 1159-1166. doi: 10.1083/jcb.200902142
60. Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., and Davies, P. (2009). Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J. Neurosci. 29, 10741-10749. doi: 10.1523/JNEUROSCI.1065-09.2009
61. Pozueta, J., Lefort, R., and Shelanski, M. L. (2013). Synaptic changes in Alzheimer's disease and its models. Neuroscience 251, 51-65. doi: 10.1016/j.neuroscience.2012.05.050
62. Riemer, J., and Kins, S. (2013). Axonal transport and mitochondrial dysfunction in Alzheimer's disease. Neurodegener. Dis. 12, 111-124. doi: 10.1159/000342020
63. Roberts, A. C., and Glanzman, D. L. (2003). Learning in Aplysia: looking at synaptic plasticity from both sides. Trends Neurosci. 26, 662-670. doi: 10.1016/j.tins.2003.09.014
64. Rocher, A. B., Crimins, J. L., Amatrudo, J. M., Kinson, M. S., Todd-Brown, M. A., Lewis, J., et al. (2010). Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs. Exp. Neurol. 223, 385-393. doi: 10.1016/j.expneurol.2009.07.029
65. Rosenmund, C., and Stevens, C. F. (1996). Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16, 1197-1207. doi: 10.1016/s0896-6273(00)80146-4
66. Sahly, I., Erez, H., Khoutorsky, A., Shapira, E., and Spira, M. E. (2003). Effective expression of the green fluorescent fusion proteins in cultured Aplysia neurons. J. Neurosci. Methods 126, 111-117. doi: 10.1016/s0165-0270(03)00072-4
67. Saul, A., Sprenger, F., Bayer, T. A., and Wirths, O. (2013). Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 34, 2564-2573. doi: 10.1016/j.neurobiolaging.2013.05.003
68. Schacher, S., and Proshansky, E. (1983). Neurite regeneration by Aplysia neurons in dissociated cell culture: modulation by Aplysia hemolymph and the presence of the initial axonal segment. J. Neurosci. 3, 2403-2413.
69. Schweizer, F. E., and Ryan, T. A. (2006). The synaptic vesicle: cycle of exocytosis and endocytosis. Curr. Opin. Neurobiol. 16, 298-304. doi: 10.1016/j.conb.2006.05.006
70. Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science 298, 789-791. doi: 10.1126/science.1074069
71. Shemesh, O. A., and Spira, M. E. (2010a). Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons. Acta Neuropathol. 120, 209-222. doi: 10.1007/s00401-010-0689-7
72. Shemesh, O. A., and Spira, M. E. (2010b). Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy. Acta Neuropathol. 119, 235-248. doi: 10.1007/s00401-009-0586-0
73. Shemesh, O. A., and Spira, M. E. (2011). Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel. Neurobiol. Dis. 43, 163-175. doi: 10.1016/j.nbd.2011.03.008
74. Shemesh, O. A., Erez, H., Ginzburg, I., and Spira, M. E. (2008). Tau-induced traffic jams reflect organelles accumulation at points of microtubule polar mismatching. Traffic 9, 458-471. doi: 10.1111/j.1600-0854.2007.00695.x
75. Spires-Jones, T., and Knafo, S. (2012). Spines, plasticity, and cognition in Alzheimer's model mice. Neural Plast. 2012:319836. doi: 10.1155/2012/319836
76. Stamer, K., Vogel, R., Thies, E., Mandelkow, E., and Mandelkow, E. M. (2002). Tau blocks traffic of organelles, neurofilaments and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063. doi: 10.1083/jcb.200108057
77. Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., et al. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282-1288. doi: 10.1126/science.1105681
78. Stoothoff, W., Jones, P. B., Spires-Jones, T. L., Joyner, D., Chhabra, E., Bercury, K., et al. (2009). Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J. Neurochem. 111, 417-427. doi: 10.1111/j.1471-4159.2009.06316.x
79. Sudhof, T. C. (2004). The synaptic vesicle cycle. Annu. Rev. Neurosci. 27, 509-547. doi: 10.1146/annurev.neuro.26.041002.131412
80. Sudo, H., and Baas, P. W. (2010). Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. J. Neurosci. 30, 7215-7226. doi: 10.1523/jneurosci.0048-10.2010
81. Sydow, A., Van Der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., et al. (2011a). Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model. J. Mol. Neurosci. 45, 432-437. doi: 10.1007/s12031-011-9604-5
82. Sydow, A., Van Der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., et al. (2011b). Tau-induced defects in synaptic plasticity, learning and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J. Neurosci. 31, 2511-2525. doi: 10.1523/jneurosci.5245-10.2011
83. Tai, H. C., Serrano-Pozo, A., Hashimoto, T., Frosch, M. P., Spires-Jones, T. L., and Hyman, B. T. (2012). The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 181, 1426-1435. doi: 10.1016/j.ajpath.2012.06.033
84. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., Deteresa, R., Hill, R., et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580. doi: 10.1002/ana.410300410
85. Thies, E., and Mandelkow, E. M. (2007). Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci. 27, 2896-2907. doi: 10.1523/jneurosci.4674-06.2007
86. Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., et al. (2001). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714. doi: 10.1126/science.1062382
87. Wu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., et al. (2013). Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J. Biol. Chem. 288, 1856-1870. doi: 10.1074/jbc.m112.394528
88. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S. M., Iwata, N., Saido, T. C., et al. (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351. doi: 10.1016/j.neuron.2007.01.010
89. Yu, W., and Lu, B. (2012). Synapses and dendritic spines as pathogenic targets in Alzheimer's disease. Neural Plast. 2012:247150. doi: 10.1155/2012/247150
90. Yu, W., Polepalli, J., Wagh, D., Rajadas, J., Malenka, R., and Lu, B. (2012). A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Abeta on synapses and dendritic spines. Hum. Mol. Genet. 21, 1384-1390. doi: 10.1093/hmg/ddr576
91. Zempel, H., Thies, E., Mandelkow, E., and Mandelkow, E. M. (2010). Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950. doi: 10.1523/JNEUROSCI.2357-10.2010
92. Zhang, B., Carroll, J., Trojanowski, J. Q., Yao, Y., Iba, M., Potuzak, J. S., et al. (2012). The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 32, 3601-3611. doi: 10.1523/jneurosci.4922-11.2012
93. Zhao, Y., and Klein, M. (2002). Modulation of the readily releasable pool of transmitter and of excitation-secretion coupling by activity and by serotonin at Aplysia sensorimotor synapses in culture. J. Neurosci. 22, 10671-10679.
94. Zhao, Y., and Klein, M. (2004). Changes in the readily releasable pool of transmitter and in efficacy of release induced by high-frequency firing at Aplysia sensorimotor synapses in culture. J. Neurophysiol. 91, 1500-1509. doi: 10.1152/jn.01019.2003